Will CRDO's FY2027 revenue exceed $2.0B?

FY2027 requires 4 quarters averaging $500M each on a ~$1.3B FY2026 base. Q4 FY2026 guided to $425-435M provides the starting point. Sequential growth of mid-single digits per quarter would reach ~$2B: $430M → $455M → $480M → $510M = $1.875B (short). To reach $2B, sequential growth needs to average ~8% per quarter, which is above the 'mid-single digit' guidance language but below Q3's 52%. Management's track record of beating guidance supports a higher trajectory, and AEC demand plus ZF Optics ramp provide growth vectors. However, $2B is a specific threshold that requires sustained execution without any quarterly hiccup.

The math is instructive: if FY2026 finishes at ~$1.33B (Q1-Q3 actual of $898M + Q4 at $435M), then 50% YoY growth gives $2.0B exactly. So the >50% growth guidance maps precisely to the $2B threshold. However, management said '>50%' which could mean 51% ($2.01B) or 55% ($2.06B). The question is whether management's >50% guidance is their typical conservative guidance (which they beat) or an aspirational target. Given they have consistently under-promised, the actual target may be $2.1-2.2B, making $2B very achievable. But the FY2026 base matters — if FY2026 finishes at $1.28B instead of $1.33B, even 55% growth gives only $1.98B.

The strongest signal is management's explicit >50% growth guidance combined with their track record of conservative guidance. If they guided >50% and have beaten guidance every quarter, the actual growth rate may be 55-65%, putting FY2027 at $2.1-2.2B. The risks are: (1) customer concentration creates lumpiness that could cause one quarter to miss, (2) hyperscaler capex reduction, (3) competitive entry slowing AEC growth. The central case favors exceeding $2B, but significant uncertainty remains given the 15-month resolution horizon.

Management guided >50% growth and has beaten every guidance target in FY2026 by significant margins. The structural AI demand driver remains intact. Five hyperscaler customers with expanding AEC deployments plus ZF Optics ramp provide multiple revenue vectors. The $2B threshold aligns with management's own minimum guidance (>50% on ~$1.33B). Given their conservative guidance history, actual FY2027 is more likely above $2B than below. Probability above 55%.

The Myth Meter's STRETCHED expectations assessment is worth taking seriously. While management has beaten guidance, FY2027 spans 4 quarters — each of which must deliver. A single quarter of customer ordering lumpiness (e.g., one hyperscaler delaying an order by 4-6 weeks across quarter boundaries) could cause a miss. The 88% customer concentration means the trajectory depends heavily on 3 customers' deployment timelines. Probability is slightly above 50% — the beat-and-raise pattern supports it, but the specific $2B threshold is at the edge of the guidance range.

The revenue trajectory supports $2B+. Q3 FY2026 at $407M is already an $1.63B annual run rate. Sustaining that run rate alone gets to $1.63B for FY2027 — well below $2B. Getting to $2B requires continued growth, averaging $500M/quarter. The step from $407M to $500M average is ~23%, which requires sustained growth momentum over 4 quarters. Given management's >50% guidance and track record, this is the base case. But execution must be near-flawless over 4 quarters.

Management guided >50% growth. They beat guidance every quarter. Structural AI demand. 5 hyperscaler customers. ZF Optics ramp. $2B aligns with minimum of guidance. Probability near 60% — management track record supports it.

The $2B threshold is at the exact lower bound of >50% growth guidance. Customer concentration creates execution risk across 4 quarters. STRETCHED expectations suggest the market may already price in $2B+. Close to a coin flip — management execution favors YES but macro and concentration risks introduce significant downside scenarios.

Management's beat-and-raise pattern is the strongest signal. >50% growth on $1.33B base exactly hits $2B. Conservative management guidance suggests actual growth will exceed 50%. Probability moderately above 50%.